Systemic treatment of cutaneous leishmaniasis: A systematic review and meta-analysis.
Systemic treatment options for CL show variable efficacy, and comparative evidence remains insufficient to support therapy recommendations, despite the promising cure rates for miltefosine and L-AmB.